Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Reducing 3α,5α-THP in the hippocampus increases seizures in female rats.

Finasteride may help treat BPH by affecting certain biological markers.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Dutasteride is as safe for the heart as finasteride.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Human liver enzyme DHEA ST helps process minoxidil.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Lowering 3α,5α-THP in the hippocampus increases anxiety and depression in proestrous rats.

Derinat helps extend hair growth by reducing harmful molecules in skin cells.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Combination therapy is more effective for prostate volumes over 60 ml.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.